OrganiGram Holdings Inc
Organigram Global Inc. engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, beverages, gummies, and concentrates; and adult use recreational cannabis under the SHRED, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co., Boxhot, Ediso… Read more
OrganiGram Holdings Inc - Asset Resilience Ratio
OrganiGram Holdings Inc (OGI) has an Asset Resilience Ratio of 0.15% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2015–2025)
This chart shows how OrganiGram Holdings Inc's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down OrganiGram Holdings Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $804.34K | 0.15% |
| Total Liquid Assets | $804.34K | 0.15% |
Asset Resilience Insights
- Limited Liquidity: OrganiGram Holdings Inc maintains only 0.15% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
OrganiGram Holdings Inc Industry Peers by Asset Resilience Ratio
Compare OrganiGram Holdings Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF |
Drug Manufacturers - Specialty & Generic | -0.02% |
|
Kamada
NASDAQ:KMDA |
Drug Manufacturers - Specialty & Generic | 21.63% |
|
Dongwha Pharm.Co.Ltd
KO:000020 |
Drug Manufacturers - Specialty & Generic | 1.92% |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078 |
Drug Manufacturers - Specialty & Generic | 0.46% |
|
Yuhan Corp.
KO:000100 |
Drug Manufacturers - Specialty & Generic | 0.99% |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153 |
Drug Manufacturers - Specialty & Generic | 1.81% |
|
Kotra Industries Bhd
KLSE:0002 |
Drug Manufacturers - Specialty & Generic | 9.82% |
|
Yuyu Pharma Inc
KO:000227 |
Drug Manufacturers - Specialty & Generic | 1.74% |
Annual Asset Resilience Ratio for OrganiGram Holdings Inc (2015–2025)
The table below shows the annual Asset Resilience Ratio data for OrganiGram Holdings Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-09-30 | 0.15% | $826.00K | $562.21 Million | -0.05pp |
| 2024-09-30 | 0.20% | $821.00K | $407.86 Million | -5.07pp |
| 2022-09-30 | 5.27% | $30.40 Million | $577.11 Million | -17.92pp |
| 2021-09-30 | 23.19% | $128.48 Million | $554.02 Million | +11.19pp |
| 2020-09-30 | 12.00% | $50.13 Million | $417.62 Million | +11.91pp |
| 2019-09-30 | 0.09% | $380.00K | $428.52 Million | -24.70pp |
| 2018-09-30 | 24.79% | $75.00 Million | $302.57 Million | -9.69pp |
| 2017-09-30 | 34.48% | $32.00 Million | $92.81 Million | -7.80pp |
| 2016-09-30 | 42.28% | $22.77 Million | $53.87 Million | -- |
| 2015-09-30 | 0.00% | $0.00 | $14.18 Million | -- |